Compare RPTX & ORIQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RPTX | ORIQ |
|---|---|---|
| Founded | 2016 | 2024 |
| Country | Canada | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.4M | 87.6M |
| IPO Year | 2020 | 2025 |
| Metric | RPTX | ORIQ |
|---|---|---|
| Price | $2.57 | $10.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 10.4K |
| Earning Date | 11-14-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,870,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2,122.22 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.89 | $9.98 |
| 52 Week High | $2.66 | $10.20 |
| Indicator | RPTX | ORIQ |
|---|---|---|
| Relative Strength Index (RSI) | 74.94 | N/A |
| Support Level | $2.15 | N/A |
| Resistance Level | $2.66 | N/A |
| Average True Range (ATR) | 0.06 | 0.00 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 83.96 | 0.00 |
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
Origin Investment Corp I is a blank check company.